Non-Hodgkin Lymphoma (NHL) Symptoms: Early Detection and Diagnostic Approach
Key Facts at a Glance
- Sample Required: Lymph node biopsy, blood sample (CBC, LDH), or bone marrow aspirate
- Fasting Rules: No fasting required for biopsy; blood tests may require 8-12 hour fasting for certain metabolic panels
- Turnaround Time (TAT): 3-7 days for histopathology and flow cytometry; 7-14 days for NGS-based mutation profiling
- Base Cost: [Insert Current 2026 Price] – varies by test complexity
What is Non-Hodgkin Lymphoma?
Non-Hodgkin Lymphoma (NHL) is a heterogeneous group of blood cancers that arise from lymphocytes—a type of white blood cell integral to the immune system. Unlike Hodgkin lymphoma, NHL lacks the characteristic Reed-Sternberg cells. The disease can manifest in lymph nodes, spleen, bone marrow, or extranodal sites. Early recognition of symptoms is critical for timely intervention and improved outcomes.
Recognizing the Warning Signs
Symptoms of NHL are often nonspecific and may mimic benign conditions. However, persistence or progression warrants medical evaluation. The following are common clinical presentations:
- Persistent, Painless Lymphadenopathy: Enlarged lymph nodes in the neck, axilla, or inguinal region that do not regress.
- Systemic B Symptoms: Unexplained fever (>38°C), drenching night sweats, and unintentional weight loss (>10% body weight over 6 months).
- Fatigue and Weakness: Chronic tiredness not relieved by rest, often due to anemia or cytokine release.
- Pruritus and Skin Changes: Generalized itching without rash, or specific skin lesions in cutaneous T-cell lymphoma.
- Respiratory Symptoms: Cough, dyspnea, or chest pain from mediastinal lymphadenopathy.
- Gastrointestinal Symptoms: Abdominal pain, bloating, early satiety, or palpable masses from retroperitoneal or mesenteric involvement.
When to Consult a Physician
If any of the above symptoms persist for more than two weeks, especially if they are progressive or accompanied by B symptoms, immediate medical consultation is advised. Early diagnosis significantly improves treatment success rates.
Diagnostic Pathway and Modern Molecular Testing
Definitive diagnosis of NHL requires histopathological examination of an excisional lymph node biopsy. Ancillary tests include:
- Immunohistochemistry (IHC): Identifies cell surface markers (CD20, CD3, etc.) to classify lymphoma subtype.
- Flow Cytometry: Evaluates clonality and immunophenotype from blood, bone marrow, or fine-needle aspirates.
- Fluorescence In Situ Hybridization (FISH): Detects chromosomal translocations (e.g., t(14;18) in follicular lymphoma).
- Next-Generation Sequencing (NGS): Identifies somatic mutations (e.g., MYD88, EZH2) for prognostic and therapeutic targeting.
- Whole Exome Sequencing (WES): In selected cases, WES can reveal germline predispositions or actionable mutations.
DNA Labs India offers comprehensive molecular diagnostics, including NGS-based panels and FISH, to support accurate classification and personalized treatment planning.
Symptom Triage Table
| Symptom | Possible Benign Cause | When to Seek Medical Advice |
|---|---|---|
| Lymph node swelling | Infection, inflammation | >2 weeks, >1 cm, firm, fixed |
| Fever & night sweats | Viral illness, TB | Persistent >3 weeks, drenching |
| Weight loss | Stress, hyperthyroidism | >10% body weight in 6 months |
| Fatigue | Anemia, sleep disorders | Interfering with daily activities |
| Itching | Dry skin, allergies | Generalized, persistent, with other symptoms |
Why Choose DNA Labs India?
DNA Labs India is an ISO 9001 certified laboratory offering advanced molecular diagnostics. Our team ensures accurate, timely results with strict quality control. We provide comprehensive support for lymphoma diagnosis and monitoring.
Written by: Dr. Ananya Sharma, MBBS, MD (Internal Medicine)
Medically Reviewed by: Dr. Rajesh Kumar, MD (Hematology)
Last Updated: March 2026